UK-based Small Pharma has announced that its DMT patent strategy has been strengthened with a new US patent protection on injectable DMT delivery in its lead...
Field Trip has now completed the dosing of the first patients in its Phase 1 clinical study: A double-blind, randomised, placebo-controlled study to investigate the safety,...
PsiloTec Health Solutions Inc.,
MAPS’ Psychedelics Fundamentals online education curriculum is aiming to introduce learners to the most important aspects of psychedelic history, research, uses and harm reduction.
Enveric Biosciences has made advancements with its drug discovery and development progress targeting mental health indications and intellectual property (IP).
The hallucinogenic effect of psychedelics may hold much healing potential, but researchers believe that these compounds could be beneficial for brain disorders without hallucinations.
Breaking Convention’s 11th conference, Worlds Collide, will feature themed panel discussions, art exhibitions and stalls.
Psychedelic Health speaks to the founder of the Psychedelic Access and Research European Alliance (PAREA), Tadeusz Hawrot, about how the organisation aims to facilitate discussions around...
Dimensions has launched its new international plant medicine retreat series in Jamaica.
The University of California, Davis (UC Davis) and the University of Colorado Anschutz Medical Campus have received a $2.7m (~£2.15m) grant from the National Institute on...